A recent study suggested that hepatocyte SHP1 might affect peroxisome proliferator–activated receptor gamma- (PPARγ-) mediated hepatic inflammation by presenting obesity-induced NAFLD [15]. Here, PPARG is linked to obesity due to melanocortin 4 receptor deficiency.